JP2021525730A5 - - Google Patents
Info
- Publication number
- JP2021525730A5 JP2021525730A5 JP2020566662A JP2020566662A JP2021525730A5 JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5 JP 2020566662 A JP2020566662 A JP 2020566662A JP 2020566662 A JP2020566662 A JP 2020566662A JP 2021525730 A5 JP2021525730 A5 JP 2021525730A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- pharmaceutically acceptable
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862677498P | 2018-05-29 | 2018-05-29 | |
| US62/677,498 | 2018-05-29 | ||
| PCT/IB2019/000691 WO2019229536A2 (en) | 2018-05-29 | 2019-05-29 | Novel benzodiazepine derivatives and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525730A JP2021525730A (ja) | 2021-09-27 |
| JP2021525730A5 true JP2021525730A5 (cg-RX-API-DMAC7.html) | 2022-06-07 |
| JP7465819B2 JP7465819B2 (ja) | 2024-04-11 |
Family
ID=68692822
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566662A Active JP7465819B2 (ja) | 2018-05-29 | 2019-05-29 | 新規ベンゾジアゼピン誘導体及びそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11084801B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3802546A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7465819B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102946423B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN112166115A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019276833A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112020023623A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3100141A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA202092909A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL278973B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020012718A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019229536A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102710962B1 (ko) | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| CN112166115A (zh) | 2018-05-29 | 2021-01-01 | 尹图赛利有限公司 | 新型苯二氮杂*衍生物及其用途 |
| EP3873912B1 (en) | 2018-10-31 | 2026-03-25 | Intocell, Inc. | Fused heterocyclic benzodiazepine derivatives and uses thereof |
| MX2021008095A (es) * | 2019-01-03 | 2021-08-05 | Intocell Inc | Compuestos que comprenden un enlazador escindible y sus usos. |
| EP3906063A4 (en) | 2019-01-03 | 2023-03-01 | Intocell, Inc. | COMPOUNDS COMPRISING A CLEAVABLE LINKER AND THEIR USES |
| CN114728075B (zh) * | 2019-12-02 | 2025-10-03 | 尹图赛利有限公司 | 与分子缀合相关的组合物和方法 |
| CN115942978A (zh) * | 2020-06-26 | 2023-04-07 | 尹图赛利有限公司 | 包含抗b7-h3抗体的抗体-药物缀合物 |
| AU2022282449A1 (en) * | 2021-05-27 | 2023-11-30 | Fusion Pharmaceuticals Inc. | 2,6-dichlorophenyl ester compounds and use thereof |
| CN119350387A (zh) * | 2022-03-03 | 2025-01-24 | 西北工业大学 | 新型可光催化剪切的羧酸保护基磷酰氧基-4-香豆素基甲基类化合物及其氨基酸衍生物的制备方法 |
| CN119424671A (zh) | 2023-08-01 | 2025-02-14 | 上海新理念生物医药科技有限公司 | 含糖基吡啶型连接子的抗体药物偶联物 |
| WO2025262641A1 (en) * | 2024-06-19 | 2025-12-26 | Pheon Therapeutics Ltd | Antibody drug conjugates that bind cdcp1 and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843937A (en) | 1996-05-23 | 1998-12-01 | Panorama Research, Inc. | DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| GB0819095D0 (en) * | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| CA3014224C (en) | 2009-02-05 | 2022-05-24 | Immunogen, Inc. | Condensed benzodiazepine-indoline derivatives and processes to prepare said derivatives |
| AU2012322934B2 (en) * | 2011-10-14 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepines |
| CA2850375C (en) | 2011-10-14 | 2019-07-02 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| HK1211208A1 (zh) | 2012-08-22 | 2016-05-20 | Immunogen, Inc. | 細胞毒性苯並二氮呯衍生物 |
| US10131682B2 (en) | 2012-11-24 | 2018-11-20 | Hangzhou Dac Biotech Co., Ltd. | Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules |
| KR102384740B1 (ko) * | 2013-12-27 | 2022-04-07 | 자임워크스 인코포레이티드 | 약물 접합체를 위한 설폰아마이드-함유 연결 시스템 |
| US10973920B2 (en) | 2014-06-30 | 2021-04-13 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| TW201632531A (zh) * | 2015-01-14 | 2016-09-16 | 必治妥美雅史谷比公司 | 苯二氮呯二聚物,其結合物及製造與使用方法 |
| CN107231804B (zh) | 2015-01-14 | 2019-11-26 | 百时美施贵宝公司 | 亚杂芳基桥连苯并二氮杂*二聚体、其缀合物及制备和使用方法 |
| KR20170128256A (ko) | 2015-03-18 | 2017-11-22 | 시애틀 지네틱스, 인크. | Cd48 항체 및 이의 접합체 |
| US9504694B2 (en) | 2015-03-19 | 2016-11-29 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| EP3458050A1 (en) | 2016-05-20 | 2019-03-27 | Abbvie Stemcentrx LLC | Anti-dll3 drug conjugates for treating tumors at risk of neuroendocrine transition |
| WO2018053552A2 (en) * | 2016-09-19 | 2018-03-22 | Cellerant Therapeutics, Inc. | Isoquinolidinobenzodiazepines |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| JP7527787B2 (ja) * | 2017-03-24 | 2024-08-05 | シージェン インコーポレイテッド | グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体 |
| WO2018195243A1 (en) | 2017-04-20 | 2018-10-25 | Immunogen, Inc. | Cytotoxic benzodiazepine derivatives and conjugates thereof |
| KR102710962B1 (ko) | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| GB201714115D0 (en) * | 2017-09-04 | 2017-10-18 | Femtogenix Ltd | Cytotoxic agents |
| CN112166115A (zh) | 2018-05-29 | 2021-01-01 | 尹图赛利有限公司 | 新型苯二氮杂*衍生物及其用途 |
| EP3873912B1 (en) | 2018-10-31 | 2026-03-25 | Intocell, Inc. | Fused heterocyclic benzodiazepine derivatives and uses thereof |
| KR102503143B1 (ko) | 2019-03-06 | 2023-02-24 | 주식회사 레고켐 바이오사이언스 | 인간 dlk1에 대한 항체를 포함하는 항체 약물 접합체 및 이의 용도 |
| CN115942978A (zh) | 2020-06-26 | 2023-04-07 | 尹图赛利有限公司 | 包含抗b7-h3抗体的抗体-药物缀合物 |
-
2019
- 2019-05-29 CN CN201980035084.3A patent/CN112166115A/zh active Pending
- 2019-05-29 CN CN202110592302.2A patent/CN113444111A/zh active Pending
- 2019-05-29 BR BR112020023623-3A patent/BR112020023623A2/pt unknown
- 2019-05-29 MX MX2020012718A patent/MX2020012718A/es unknown
- 2019-05-29 AU AU2019276833A patent/AU2019276833A1/en not_active Abandoned
- 2019-05-29 CA CA3100141A patent/CA3100141A1/en active Pending
- 2019-05-29 IL IL278973A patent/IL278973B2/en unknown
- 2019-05-29 WO PCT/IB2019/000691 patent/WO2019229536A2/en not_active Ceased
- 2019-05-29 EA EA202092909A patent/EA202092909A1/ru unknown
- 2019-05-29 KR KR1020207037031A patent/KR102946423B1/ko active Active
- 2019-05-29 JP JP2020566662A patent/JP7465819B2/ja active Active
- 2019-05-29 EP EP19811692.3A patent/EP3802546A4/en active Pending
- 2019-05-29 US US16/425,237 patent/US11084801B2/en active Active
-
2021
- 2021-06-30 US US17/363,814 patent/US11807628B2/en active Active
-
2023
- 2023-06-05 AU AU2023203485A patent/AU2023203485B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022510505A5 (cg-RX-API-DMAC7.html) | ||
| JP7229202B2 (ja) | 標的化薬物結合体と使用するためのメチレンカルバメートリンカー | |
| CN114053426B (zh) | 一种双药链接组装单元及双药靶向接头-药物偶联物 | |
| JP2025510629A (ja) | カンプトテシンコンジュゲート | |
| FI105155B (fi) | Menetelmä terapeuttisesti käyttökelpoisten sappihappojohdannaisten valmistamiseksi | |
| JP2022082777A (ja) | Peg化薬物リンカー及びその中間体を調製するためのプロセス | |
| JP2022527114A5 (cg-RX-API-DMAC7.html) | ||
| JP2023105175A (ja) | グルクロニド薬物-リンカーの調製のためのプロセスおよびその中間体 | |
| KR20220052918A (ko) | 치료제로서의 사이토톡신의 펩티드 접합체 | |
| MXPA05010471A (es) | Profarmacos inhibidores de quinasa pi-3. | |
| JP6929292B2 (ja) | 新規なクリプトフィシン化合物およびコンジュゲート、これらの製造およびこれらの治療用途 | |
| IL315310A (en) | Irak degraders and uses thereof | |
| US20090246211A1 (en) | Molecular constructs suitable for targeted conjugates | |
| JP2006523237A5 (cg-RX-API-DMAC7.html) | ||
| KR20180030993A (ko) | 항체-약물 접합체 중의 공유결합 링커 및 이의 제조방법 및 사용방법 | |
| CN101909441A (zh) | 微管蛋白抑制剂及其制备方法 | |
| JP2012516896A5 (cg-RX-API-DMAC7.html) | ||
| KR20160045146A (ko) | 마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도 | |
| CN105899515A (zh) | uncialamycin的衍生物、合成方法及其作为抗肿瘤剂的用途 | |
| JP2022515884A5 (cg-RX-API-DMAC7.html) | ||
| JP2018512424A (ja) | エステル化のための試薬及び方法 | |
| Makarov et al. | Modification of 3, 5-bis (arylidene)-4-piperidone pharmacophore by phosphonate group using 1, 2, 3-triazole cycle as a linker for the synthesis of new cytostatics | |
| CN114874204A (zh) | 靶向SARS-CoV-2 3C蛋白酶的PROTAC分子及其应用 | |
| US11117907B2 (en) | Curcuminoid-inspired synthetic compounds as anti-tumor agents | |
| TWI825169B (zh) | 妥布賴森(tubulysins)及其中間體之製備之替代方法 |